Dec 03, Colombo: Following the discovery of a piece of glass in an injectable antibiotic vial, the Health Ministry of Sri Lanka said that it will formulate new regulations to deal with the suppliers of substandard drugs.
The Ministry has decided to formulate regulations to blacklist suppliers or manufactures that would have 10 instances of questionable supplies within a period of three years and fully recover the expenses and damages the Ministry would incur due to the supply of substandard drug.
The Ministry has also considered amending the tender procedure for procuring drugs.
The Health Ministry banned the use of the injectable antibiotic Cloxacillin supplied by an Indian manufacturer in all state hospitals after a sliver of glass has been found in one of the vials at the Kalubowila Hospital.
Health Minister, Maithripala Sirisena ordered an immediate inquiry into the incident and said the report of the investigation on the Cloxacillin vials will be sent to the Indian government.
He said follow up action against the manufacturer, Biomet Pharmaceutical Company of India, would be considered based on the findings of the report.
India has assured its fullest cooperation to Colombo and action against the company in question.
The Health Ministry has previously taken action against Indian companies that supplied low-quality drugs.
About 70 percent of the pharmaceuticals used in the country are imported from India.